Company Filing History:
Years Active: 2020-2025
Title: The Innovative Contributions of Ki Hwan Eum
Introduction
Ki Hwan Eum is a notable inventor based in Ansan-si, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of neuronal diseases. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
One of Ki Hwan Eum's latest patents is a pharmaceutical composition comprising AIMP2-DX2 for preventing or treating neuronal diseases. This composition includes an exon 2-deleted AIMP2 variant (AIMP2-DX2) gene or a vector containing the gene. The method outlined in the patent focuses on treating neuronal diseases in animals other than humans. The active ingredient has shown effects such as apoptosis inhibition, dyskinesia amelioration, and oxidative stress inhibition. This makes it a promising candidate for preventing and treating conditions like Parkinson's disease and amyotrophic lateral sclerosis.
Career Highlights
Ki Hwan Eum is currently associated with Generoath Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research and development efforts are aimed at creating effective treatments for complex neurological conditions.
Collaborations
He collaborates with talented individuals such as Jin Woo Choi and Dong Uk Lee, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ki Hwan Eum's work exemplifies the impact of innovative thinking in the medical field. His contributions are vital for the advancement of treatments for neuronal diseases, showcasing the importance of research and collaboration in achieving significant breakthroughs.